Successful use of rituximab for refractory hemophagocytic lymphohistiocytosis in a melanoma patient treated with targeted therapy : Melanoma Research

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Short Communications: Clinical Research

Successful use of rituximab for refractory hemophagocytic lymphohistiocytosis in a melanoma patient treated with targeted therapy

Tejedor, Ines; Tedbirt, Billal; Carvalho, Priscille; Duval-Modeste, Anne Bénédicte; Joly, Pascal; Hébert, Vivien

Author Information
doi: 10.1097/CMR.0000000000000845
  • Buy

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.